183 related articles for article (PubMed ID: 17317901)
21. Neurofibromatosis type 1 clinical features and management.
Scalzone M; Coccia P; Ruggiero A; Riccardi R
Pediatr Med Chir; 2009; 31(6):246-51. PubMed ID: 20333883
[TBL] [Abstract][Full Text] [Related]
22. Minor disease features in neurofibromatosis type 1 (NF1) and their possible value in diagnosis of NF1 in children < or = 6 years and clinically suspected of having NF1. Neurofibromatosis team of Sophia Children's Hospital.
Cnossen MH; Moons KG; Garssen MP; Pasmans NM; de Goede-Bolder A; Niermeijer MF; Grobbee DE
J Med Genet; 1998 Aug; 35(8):624-7. PubMed ID: 9719365
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of tibial osteopathy occurrence in neurofibromatosis type 1 Italian patients.
Morcaldi G; Clementi M; Lama G; Gabrielli O; Vannelli S; Virdis R; Vivarelli R; Boero S; Bonioli E
Am J Med Genet A; 2013 May; 161A(5):927-34. PubMed ID: 23463485
[TBL] [Abstract][Full Text] [Related]
24. Natural history and outcome of optic pathway gliomas in children.
Nicolin G; Parkin P; Mabbott D; Hargrave D; Bartels U; Tabori U; Rutka J; Buncic JR; Bouffet E
Pediatr Blood Cancer; 2009 Dec; 53(7):1231-7. PubMed ID: 19621457
[TBL] [Abstract][Full Text] [Related]
25. Clinical Presentation and Outcome of Patients With Optic Pathway Glioma.
Robert-Boire V; Rosca L; Samson Y; Ospina LH; Perreault S
Pediatr Neurol; 2017 Oct; 75():55-60. PubMed ID: 28847625
[TBL] [Abstract][Full Text] [Related]
26. Predictive value of café au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1.
Nunley KS; Gao F; Albers AC; Bayliss SJ; Gutmann DH
Arch Dermatol; 2009 Aug; 145(8):883-7. PubMed ID: 19687418
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic delay of NF1 in hemifacial hypertrophy due to plexiform neurofibromas.
Overdiek A; Feifel H; Schaper J; Mayatepek E; Rosenbaum T
Brain Dev; 2006 Jun; 28(5):275-80. PubMed ID: 16481142
[TBL] [Abstract][Full Text] [Related]
28. Juvenile xanthogranuloma and nevus anemicus in the diagnosis of neurofibromatosis type 1.
Ferrari F; Masurel A; Olivier-Faivre L; Vabres P
JAMA Dermatol; 2014 Jan; 150(1):42-6. PubMed ID: 24258576
[TBL] [Abstract][Full Text] [Related]
29. Retrospective analysis of patients attending a neurofibromatosis type 1 clinic.
Noble F; Kornberg AJ; Elder JE; Delatycki MB
J Paediatr Child Health; 2007; 43(1-2):55-9. PubMed ID: 17207057
[TBL] [Abstract][Full Text] [Related]
30. [Long-term outcome of gliomas of the visual pathway in type 1 neurofibromatosis].
Schröder S; Baumann-Schröder U; Hazim W; Haase W; Mautner VF
Klin Monbl Augenheilkd; 1999 Dec; 215(6):349-54. PubMed ID: 10637799
[TBL] [Abstract][Full Text] [Related]
31. [Care recommendations for type 1 neurofibromatosis].
Donadio A; Garavelli L; Lorenzetti ME; Villani AR; Banchini G; Virdis R
Acta Biomed Ateneo Parmense; 2000; 71(3-4):83-7. PubMed ID: 11424620
[TBL] [Abstract][Full Text] [Related]
32. Clinic-based study of plexiform neurofibromas in neurofibromatosis 1.
Waggoner DJ; Towbin J; Gottesman G; Gutmann DH
Am J Med Genet; 2000 May; 92(2):132-5. PubMed ID: 10797438
[TBL] [Abstract][Full Text] [Related]
33. Seizures in children with neurofibromatosis type 1: is neurofibromatosis type 1 enough?
Santoro C; Bernardo P; Coppola A; Pugliese U; Cirillo M; Giugliano T; Piluso G; Cinalli G; Striano S; Bravaccio C; Perrotta S
Ital J Pediatr; 2018 Mar; 44(1):41. PubMed ID: 29566708
[TBL] [Abstract][Full Text] [Related]
34. Calvarial defects and skeletal dysplasia in patients with neurofibromatosis Type 1.
Arrington DK; Danehy AR; Peleggi A; Proctor MR; Irons MB; Ullrich NJ
J Neurosurg Pediatr; 2013 Apr; 11(4):410-6. PubMed ID: 23414129
[TBL] [Abstract][Full Text] [Related]
35. Cerebral arteriopathy in children with neurofibromatosis type 1.
Rea D; Brandsema JF; Armstrong D; Parkin PC; deVeber G; MacGregor D; Logan WJ; Askalan R
Pediatrics; 2009 Sep; 124(3):e476-83. PubMed ID: 19706560
[TBL] [Abstract][Full Text] [Related]
36. [Magnetic resonance imaging findings of orbital disease in neurofibromatosis type 1 patients].
Fu L; Wang ZC; Xian JF; Li J; Zhang ZY
Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(29):2042-5. PubMed ID: 23253805
[TBL] [Abstract][Full Text] [Related]
37. Visual acuity of children treated with chemotherapy for optic pathway gliomas.
Kalin-Hajdu E; Décarie JC; Marzouki M; Carret AS; Ospina LH
Pediatr Blood Cancer; 2014 Feb; 61(2):223-7. PubMed ID: 23956233
[TBL] [Abstract][Full Text] [Related]
38. Glaucoma and globe enlargement associated with neurofibromatosis type 1.
Morales J; Chaudhry IA; Bosley TM
Ophthalmology; 2009 Sep; 116(9):1725-30. PubMed ID: 19729098
[TBL] [Abstract][Full Text] [Related]
39. Neurofibromatosis type 1: update on a common genetic condition.
Siqveland E; Pond D
Minn Med; 2009 Mar; 92(3):49-52. PubMed ID: 19400389
[TBL] [Abstract][Full Text] [Related]
40. Neurofibromatosis type 1 and malignancy in childhood.
Varan A; Şen H; Aydın B; Yalçın B; Kutluk T; Akyüz C
Clin Genet; 2016 Mar; 89(3):341-5. PubMed ID: 26073032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
